
Sign up to save your podcasts
Or
This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.
4.7
127127 ratings
This week's View summarizes articles on empagliflozin improving CV outcomes irrespective of blood pressure, the efficacy of the COVID-19 vaccine at 6 months post-vaccination, and the protection of the COVID-19 booster dose in Israel.
131 Listeners
322 Listeners
161 Listeners
861 Listeners
491 Listeners
32 Listeners
278 Listeners
87 Listeners
1,087 Listeners
61 Listeners
39 Listeners
185 Listeners
348 Listeners
420 Listeners
37 Listeners